• Eczema
  • COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Newsletter01.18Ulrich wahnProfessor Ulrich Wahn is a German PhD Paediatric allergologist with over 40 years’ experience. He has served as President of the European Academy of Allergy and Clinical Immunology (EAACI) from 2003-2005. 

For some decades already, some allergy patients can start a treatment option called allergen immunotherapy (AIT). Immunotherapy involves exposing patients to larger and larger amounts of allergen in an attempt to change the immune system's response. The efficacy of AIT has been proven in allergic rhinitis and allergic asthma, but according to the European Academy of Allergy and Clinical Immunology (EAACI), less than 1 patient out of 10 has tried the treatment. New findings obtained from Real World Evidence data could change this trend.